166 related articles for article (PubMed ID: 35755052)
1. Uveal Effusion Syndrome: Clinical Characteristics, Outcome of Surgical Treatment, and Histopathological Examination of the Sclera.
Zhou N; Yang L; Xu X; Wei W
Front Med (Lausanne); 2022; 9():785444. PubMed ID: 35755052
[TBL] [Abstract][Full Text] [Related]
2. Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology.
Uyama M; Takahashi K; Kozaki J; Tagami N; Takada Y; Ohkuma H; Matsunaga H; Kimoto T; Nishimura T
Ophthalmology; 2000 Mar; 107(3):441-9. PubMed ID: 10711879
[TBL] [Abstract][Full Text] [Related]
3. Unusual non-nanophthalmic uveal effusion syndrome with histologically normal scleral architecture: a case report.
Kaewsangthong K; Thoongsuwan S; Uiprasertkul M; Phasukkijwatana N
BMC Ophthalmol; 2020 Jul; 20(1):311. PubMed ID: 32727414
[TBL] [Abstract][Full Text] [Related]
4. Comparing the Results of Vitrectomy and Sclerectomy in a Patient with Nanophthalmic Uveal Effusion Syndrome.
Popov I; Popova V; Krasnik V
Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33572746
[TBL] [Abstract][Full Text] [Related]
5. Uveal effusion syndrome.
Elagouz M; Stanescu-Segall D; Jackson TL
Surv Ophthalmol; 2010; 55(2):134-45. PubMed ID: 20159229
[TBL] [Abstract][Full Text] [Related]
6. Bilateral Pachychoroid disease with type 3 Uveal effusion syndrome in one eye and central serous Chorioretinopathy in contralateral eye: a case report.
Onoe H; Shimada H; Kawamura A; Hirosawa H; Tanaka K; Mori R; Nakashizuka H
BMC Ophthalmol; 2022 Feb; 22(1):91. PubMed ID: 35197001
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and surgical treatment of idiopathic uveal effusion syndrome.
Shen ZJ; Shen L; Wang H
Int J Ophthalmol; 2022; 15(4):604-608. PubMed ID: 35450194
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation and treatment outcomes of an algorithmic approach to uveal effusion syndrome.
Desai A; Parameswarappa DC; Senthil S; Jayanna S; Pappuru RR; Jalali S; Rani PK
Indian J Ophthalmol; 2022 Dec; 70(12):4349-4356. PubMed ID: 36453343
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Nanophthalmos-Related Uveal Effusion with Two- vs. Four-Quadrant Partial-Thickness Sclerectomy and Sclerotomy Surgery.
Özdek Ş; Yalınbaş Yeter D; Özmen MC; Hasanreisoğlu M
Turk J Ophthalmol; 2022 Feb; 52(1):37-44. PubMed ID: 35196838
[TBL] [Abstract][Full Text] [Related]
10. Uveal effusion syndrome mimicking severe chronic posterior uveitis: a case series of seven eyes of four patients.
Maggio E; Polito A; Prigione G; Pertile G
Graefes Arch Clin Exp Ophthalmol; 2016 Mar; 254(3):545-52. PubMed ID: 26376819
[TBL] [Abstract][Full Text] [Related]
11. Extensive circumferential partial-thickness sclerectomy in eyes with extreme nanophthalmos and spontaneous uveal effusion.
Mansour A; Stewart MW; Shields CL; Hamam R; Abdul Fattah M; Sheheitli H; Mehanna CJ; Yassine S; Chahine H; Keaik M; Maalouf F; Jaroudi M
Br J Ophthalmol; 2019 Dec; 103(12):1862-1867. PubMed ID: 30877130
[TBL] [Abstract][Full Text] [Related]
12. A modified ultrasound-guided surgical technique for the management of the uveal effusion syndrome in patients with normal axial length and scleral thickness.
Ghazi NG; Richards CP; Abazari A
Retina; 2013 Jun; 33(6):1211-9. PubMed ID: 23503341
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of uveal effusion syndrome: a case series and literature review.
Chan W; Fang-tian D; Hua Z; You-xin C; Rong-ping D; Ke T
Chin Med Sci J; 2011 Dec; 26(4):231-6. PubMed ID: 22218051
[TBL] [Abstract][Full Text] [Related]
14. Resolution of serous retinal detachment following partial sclerectomy with mitomycin C in nanophthalmos.
Venkatesh P; Majumdar SS; Kakkar A; Singh S; Gogia V; Garg S
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(3):287-9. PubMed ID: 23676234
[TBL] [Abstract][Full Text] [Related]
15. Familial Nanophthalmos Presenting with Spontaneous Uveal Effusion Syndrome.
Bansal R; Menia NK; Gupta A
Ocul Immunol Inflamm; 2020; 28(2):191-193. PubMed ID: 30556758
[No Abstract] [Full Text] [Related]
16. UVEAL EFFUSION ASSOCIATED WITH LOCALIZED SCLERODERMA BECAUSE OF SCLERAL FIBROSIS.
Li S; Liu W; Zhao M; Li Y; Li X; Shi X
Retin Cases Brief Rep; 2023 Jul; 17(4):406-409. PubMed ID: 37364200
[TBL] [Abstract][Full Text] [Related]
17. A Retrospective Case Series of Uveal Effusion Syndrome.
Claeys E; Stalmans P; Van Calster J; Casteels I; Stalmans I; Vandewalle E
J Glaucoma; 2020 Oct; 29(10):995-998. PubMed ID: 32769728
[TBL] [Abstract][Full Text] [Related]
18. CLINICAL CHARACTERISTICS, TREATMENT MODALITIES, AND THEIR ASSOCIATION WITH LONG-TERM VISUAL OUTCOMES IN UVEAL EFFUSION SYNDROME.
Choi EY; Lee SM; Chun J; Choi YJ; Kim M
Retina; 2024 Apr; 44(4):642-651. PubMed ID: 38109673
[TBL] [Abstract][Full Text] [Related]
19. Partial thickness sclerectomy and intravitreal anti-VEGF therapy for intractable uveal effusion syndrome.
Guo J; Cao X; Li X
Int Ophthalmol; 2019 Aug; 39(8):1885-1890. PubMed ID: 30043134
[TBL] [Abstract][Full Text] [Related]
20. Appearance of Tumor Vessels in Patients With Choroidal Osteoma Using Swept-Source Optical Coherence Tomographic Angiography.
Zhou N; Xu X; Liu Y; Wei W; Peng X
Front Oncol; 2021; 11():762394. PubMed ID: 34790578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
